Skip to Main Content

Given that President Trump is famous for his Earth-shaking tweets, it seems appropriate to comb through Twitter reactions to his administration’s new drug pricing plan, which was unveiled Friday.

Many experts, analysts, and journalists noted the lack of detail in the proposals and the disconnect between Trump’s harsh words against drug makers and pharmacy benefit managers versus how the plan could actually affect industry players. They also pointed out that this plan is just that — any actual changes would need future regulatory moves or congressional action.


One proposal that caught people’s attention was the idea of requiring drug companies to disclose prices in their advertisements, though there were questions about that as well:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!